Federal health officials say that the manufacturer of a medical instrument at the center of a recent “superbug” outbreak in Los Angeles did not receive federal clearance to sell the device.
The Food and Drug Administration has confirmed that Olympus Corp. did not seek FDA clearance for the latest version of its specialized endoscope, which it began selling in 2010. FDA clearance is required for all substantive updates to medical device sold in the U.S.
Despite the lack of clearance, the FDA said doctors should continue using the device because it’s not clear that a federal review would have prevented the recent infections.
Olympus has now submitted an application for the device that is currently under FDA review
Was this article valuable?
Here are more articles you may enjoy.
How One Fla. Insurance Agent Allegedly Used Another’s License to Swipe Commissions
Trump’s Repeal of Climate Rule Opens a ‘New Front’ for Litigation
What Analysts Are Saying About the 2026 P/C Insurance Market
Experian Launches Insurance Marketplace App on ChatGPT 

